Protagenic Therapeutics I... (PTIX)
NASDAQ: PTIX
· Real-Time Price · USD
3.05
-0.15 (-4.69%)
At close: Oct 16, 2025, 3:59 PM
3.01
-1.31%
After-hours: Oct 16, 2025, 07:15 PM EDT
-4.69% (1D)
| Bid | 3.01 |
| Market Cap | 2.65M |
| Revenue (ttm) | -25.14K |
| Net Income (ttm) | -8.69M |
| EPS (ttm) | -13.13 |
| PE Ratio (ttm) | -0.23 |
| Forward PE | n/a |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 3.6 |
| Volume | 49,287 |
| Avg. Volume (20D) | 2,679,973 |
| Open | 3.21 |
| Previous Close | 3.20 |
| Day's Range | 3.04 - 3.32 |
| 52-Week Range | 2.25 - 15.26 |
| Beta | 0.38 |
| Ex-Dividend Date | n/a |
About PTIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PTIX
Website n/a
1 month ago
+6.37%
Protagenic Therapeutics shares are trading higher ...
Unlock content with
Pro Subscription
1 month ago
+86.84%
Protagenic Therapeutics shares are trading higher after the company announced it has completed the first dose injections in its Phase 1 multiple-dose study of PT00114.
1 month ago · accessnewswire.com
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq ComplianceDelay Attributable to Merger-Related Financial Consolidation NEW YORK, NY / ACCESS Newswire / August 22, 2025 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX), a biopharmaceutical company developing nove...
